A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This 4 arm study will investigate the pharmacodynamics and pharmacokinetics of RO4998452 in
type 2 diabetes patients with varying degrees of renal impairment. Eligible patients will be
divided into 4 groups, with normal renal function, or mild, moderate or severe renal
impairment. All patients will receive a single oral dose of RO4998452 in the fasted state.The
anticipated time on study treatment is <3 months (single dose study)and the target sample
size is <100 individuals.